- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05163418
Validation of Plantar Orthoses for Abnormal Plantar Arch Using a New Non-invasive Clinical Imaging System
March 2, 2023 updated by: TOPMED
The goal of this project is to validate a new non-invasive clinical imaging system to evaluate the efficacy of plantar orthotics and to assess the biomechanical efficiency of plantar orthotics for people with flat or high arch feet.
The Cryovizion system should detect changes in participants' posture with an accuracy of 95%, while orthotics should improve the body's postural symmetry index.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yoann Dessery, PhD
- Phone Number: 4187801301
- Email: ydessery@topmed.ca
Study Contact Backup
- Name: Edith Martin, PhD
- Phone Number: 4187801301
- Email: emartin@topmed.ca
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada, G1S1C1
- TOPMED
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI<30
- No pain
- No musculoskeletal disorders
- No balance disorders
- No pathologies linked to the central nervous system
- No use of drugs affecting the balance
Exclusion Criteria:
- People with foot pathology other than the arch;
- People with diabetes ;
- People with severe obesity ;
- People wearing high heel shoes regularly ;
- People with degenerative disease ;
- People with neuromuscular pathology ;
- People with a circulatory disorder ;
- People who have had major lower body surgery;
- Inability to walk 30 minutes continuously.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Flat feet
People with flat feet according to foot posture index (validated by clinical assessment)
|
Plantar orthotics based on a unique process of footprinting, software design and orthotic printing to create custom 3D printed orthotics.
|
Experimental: High arches feet
People with high arches feet according to foot posture index (validated by clinical assessment)
|
Plantar orthotics based on a unique process of footprinting, software design and orthotic printing to create custom 3D printed orthotics.
|
No Intervention: Normal arches feet (control group)
Control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in body's postural symmetry index at 2 months
Time Frame: Baseline and 2 months
|
Change in body's postural symmetry index at 2 months after the beginning of the intervention.
This index is calculated based on the Cryovision topographic color imaging system.
|
Baseline and 2 months
|
Change from baseline in body's postural symmetry index at 6 months
Time Frame: Baseline and 6 months
|
Change in body's postural symmetry index at 6 months after the beginning of the intervention.
This index is calculated based on the Cryovision topographic color imaging system.
|
Baseline and 6 months
|
Change from baseline in body's postural symmetry index at 12 months
Time Frame: Baseline and 12 months
|
Change in body's postural symmetry index at 12 months after the beginning of the intervention.
This index is calculated based on the Cryovision topographic color imaging system.
|
Baseline and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in flexion-extension angles of lower body joints during gait at 2 months
Time Frame: Baseline and 2 months
|
Change in anteroposterior range of motion of the ankle, knee and hip joints when walking measured with a Vicon motion capture system at 2 months.
|
Baseline and 2 months
|
Change from baseline in flexion-extension angles of lower body joints during gait at 6 months
Time Frame: Baseline and 6 months
|
Change in anteroposterior range of motion of the ankle, knee and hip joints when walking measured with a Vicon motion capture system at 6 months.
|
Baseline and 6 months
|
Change from baseline in flexion-extension angles of lower body joints during gait at 12 months
Time Frame: Baseline and 12 months
|
Change in anteroposterior range of motion of the ankle, knee and hip joints when walking measured with a Vicon motion capture system at 12 months.
|
Baseline and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Edith Martin, PhD, TOPMED
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 8, 2021
Primary Completion (Anticipated)
June 15, 2024
Study Completion (Anticipated)
July 1, 2024
Study Registration Dates
First Submitted
December 15, 2021
First Submitted That Met QC Criteria
December 15, 2021
First Posted (Actual)
December 20, 2021
Study Record Updates
Last Update Posted (Estimate)
March 6, 2023
Last Update Submitted That Met QC Criteria
March 2, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RD-19-0241_CrA_Valg
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Flat Feet
-
University of ExtremaduraCompleted
-
Istituto Ortopedico RizzoliRecruitingFlat Feet | Subtalar Arthrorisis | Growth AgeItaly
-
Istituto Ortopedico RizzoliCompletedSurgery | Sports Physical Therapy | Flat FeetItaly
-
Mahmoud Ali Hassan AbdelhamidNot yet recruitingTreatment Of Symptomatic Pes Planus By Sinus Tarsi Screw Versus Conical Subtalar Screw ArthroereisisSymptomatic Flexible Flat Feet
-
National Yang Ming UniversityTerminatedFlat Feet | Forefoot VarusTaiwan
-
Istituto Ortopedico RizzoliUnknown
-
NHS Greater Glasgow and ClydeUniversity of Central LancashireCompletedFoot Ankle Injuries | Foot Injury | Foot Deformity | Foot Sprain | Feet, FlatUnited Kingdom
-
Orthopedic Hospital Vienna SpeisingRecruitingDeformity, Foot | Flexor Tendon Rupture | Flat Feet | Tibialis Posterior DysfunctionAustria
Clinical Trials on Foot orthoses for high arches feet
-
University of Wisconsin, MadisonUnited States Department of DefenseRecruiting
-
Chinese University of Hong KongPamela Youde Nethersole Eastern HospitalActive, not recruitingMetatarsalgiaHong Kong
-
Mayo ClinicCompleted